Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis.
about
Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma.A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum.CD8+ T cells define an unexpected role in live-attenuated vaccine protective immunity against Chlamydia trachomatis infection in macaquesIn situ analysis of the evolution of the primary immune response in murine Chlamydia trachomatis genital tract infection.Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells.Persistent Chlamydia trachomatis infections resist apoptotic stimuli.Enhanced upper genital tract pathologies by blocking Tim-3 and PD-L1 signaling pathways in mice intravaginally infected with Chlamydia muridarum.Immunity to murine chlamydial genital infection.The major CD8 T cell effector memory subset in the normal and Chlamydia trachomatis-infected human endocervix is low in perforinPerforin is detrimental to controlling [corrected] C. muridarum replication in vitro, but not in vivo.Chlamydia-specific CD4 T cell clones control Chlamydia muridarum replication in epithelial cells by nitric oxide-dependent and -independent mechanisms.The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis.A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infectionTranscutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infectionProtective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.Plac8-dependent and inducible NO synthase-dependent mechanisms clear Chlamydia muridarum infections from the genital tractChlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis.Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells.Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection.Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxinVaginal chlamydial clearance following primary or secondary infection in mice occurs independently of TNF-α.The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells.Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models.Role of CD8(+)T cells in the host response to ChlamydiaCytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic.
P2860
Q33490124-44C2E0E1-C4F5-4317-AB9C-F0DFF8899BADQ33606828-C84D4638-4981-4B1E-BB59-3B169196AA00Q33620511-C10AD4E5-B034-4A50-8CCD-34F0586E3685Q34004414-29BB110C-D0EE-49D6-9FCC-280F642BA564Q34005295-44D32073-4944-424A-848E-31DF790EBAD0Q34006912-FBC47E94-D597-4747-B125-8F75FED887BDQ34100837-503F90F2-D3BB-4AA9-A917-A38D95574550Q34124225-01E0A146-4FEE-4189-B75F-EFBBE4898852Q34502654-9340AEE3-2B08-4BCB-9565-57ADA98B53AEQ34730267-9A68237A-718E-4021-AE3A-C263D0026E41Q34774853-18700D9C-9183-4C57-A5EA-AEB37B9738E2Q34975886-87245E37-29DE-4A72-B44B-879FA9C15878Q34980175-FD375236-33B5-441D-BEC4-538A70C7862EQ35329016-E9EFC941-5A16-4A52-BB2F-323936AC2B5EQ35550138-242C3306-30CD-42D2-9FB1-B48BC3F7AB40Q35634194-750390BF-A553-4F00-82F7-5CE2550FE56BQ35829883-8C7A22F1-5335-4ACD-BB5A-59FEA05855FDQ36227486-9E177383-C718-4A23-8439-6E343869ED48Q36404360-25CF7345-53C4-413D-A9F3-16D720E9A13BQ36421541-59463EBC-D215-4D66-B6EA-E6FEFD00CA33Q36593534-3D36FABC-0400-4543-BCA9-47B04AAABC6EQ36672211-8AE8B9A6-FE52-40AA-B0DA-5645FE4E6099Q36804245-84C8FDA3-AC1F-480F-A39C-4FD4B598FC0AQ37087607-23682C77-64B8-4218-A837-553C51A0741BQ37093100-478C2C39-0E79-43CA-A886-607DCC58C27FQ37623839-0B5788A6-304C-424D-A389-41DF5A7B1B79
P2860
Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Clearance of Chlamydia trachom ...... sis or Fas-mediated apoptosis.
@ast
Clearance of Chlamydia trachom ...... sis or Fas-mediated apoptosis.
@en
Clearance of Chlamydia trachom ...... sis or Fas-mediated apoptosis.
@nl
type
label
Clearance of Chlamydia trachom ...... sis or Fas-mediated apoptosis.
@ast
Clearance of Chlamydia trachom ...... sis or Fas-mediated apoptosis.
@en
Clearance of Chlamydia trachom ...... sis or Fas-mediated apoptosis.
@nl
prefLabel
Clearance of Chlamydia trachom ...... sis or Fas-mediated apoptosis.
@ast
Clearance of Chlamydia trachom ...... sis or Fas-mediated apoptosis.
@en
Clearance of Chlamydia trachom ...... sis or Fas-mediated apoptosis.
@nl
P2093
P2860
P1476
Clearance of Chlamydia trachom ...... ysis or Fas-mediated apoptosis
@en
P2093
P2860
P304
P407
P577
1999-03-01T00:00:00Z